Higano CS, Corman JM, Smith DC, et al. Phase 1/2 do se-escalation study of a GM -CSF–secreting, allogeneic, cellular immunotherapy for metastatic hormone -refractory prostate cancer. Cancer 2008 ; 113: 975-9 84.